
Institute of Biomedical Research Corp.
MRESOTCHealthcare● Active
$0.00
+$0.00(+15.38%)
Market Cap$4056731
P/E Ratio—
52W High$0.0197
52W Low$0.0007
Institute of Biomedical Research Corp.(MRES)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · MRES · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.05M | $0.05M | $0.03M | $0.00M | $0.00M |
| Cost of Revenue | $0.03M | $0.04M | $0.02M | $0.00M | $0.00M |
| Gross Profit | $0.02M | $0.01M | $0.01M | $0.00M | $0.00M |
| Gross Margin %(computed) | 43.25% | 18.97% | 29.46% | — | — |
| Operating Expenses | |||||
| R&D Expenses | ($0.11M) | $0.21M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $0.78M | $1.80M | $0.73M | $0.17M | $0.04M |
| Operating Income | ($0.76M) | ($1.80M) | ($0.72M) | ($0.17M) | ($0.04M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.02M | $0.04M | $0.05M | $0.00M | $0.00M |
| Income Before Tax | ($0.74M) | $1.36M | ($0.43M) | ($0.17M) | ($0.04M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.63M) | $1.33M | ($0.43M) | ($0.17M) | ($0.04M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $0.00 | $-0.00 | $-0.00 | $0.00 |
| Wtd Avg Shares | 2663.61M | 2371.42M | 1454.64M | 915.79M | 915.79M |
| EBITDA | ($0.72M) | $1.39M | ($0.38M) | ($0.17M) | ($0.04M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M
深入了解Institute of Biomedical Research Corp.
关于Institute of Biomedical Research Corp.(MRES)损益表
Institute of Biomedical Research Corp.(MRES)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,MRES实现营收$0.00B,毛利润$0.00B(毛利率43.25%),净利润($0.00B)(净利率-1278.56%)。
常见问题
MRES · 4 问Institute of Biomedical Research Corp.(MRES)2025财年营收为$0.00B,同比up9.8%。
MRES revenueMRES salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09